Gene therapy randomised clinical trials in Europe – a review paper of methodology and design
Purpose: Gene therapy brings opportunities to discover cures for diseases for which there are no adequate treatments. As most gene therapies target rare diseases, several challenges are associated with their clinical development, such as limited population size, lack of established clinical pathways...
Main Authors: | Krassimira Ilieva, Borislav Borissov, Mondher Toumi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Journal of Market Access & Health Policy |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20016689.2020.1847808 |
Similar Items
-
Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in Europe
by: Andreas M. Farkas, et al.
Published: (2017-05-01) -
Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework
by: Marta Carvalho, et al.
Published: (2017-10-01) -
Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports
by: Ryosuke Kurauchi, et al.
Published: (2020-12-01) -
Editorial: Clinical Translation and Commercialisation of Advanced Therapy Medicinal Products
by: Ivan Martin, et al.
Published: (2020-12-01) -
Advanced Therapy Medicinal Products for the Eye: Definitions and Regulatory Framework
by: Marina López-Paniagua, et al.
Published: (2021-03-01)